ID: ALA2261621

Max Phase: Preclinical

Molecular Formula: C14H8BrN3O2

Molecular Weight: 330.14

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C1C(Nc2ccc(Br)cc2)=CC(=O)c2ncncc21

Standard InChI:  InChI=1S/C14H8BrN3O2/c15-8-1-3-9(4-2-8)18-11-5-12(19)13-10(14(11)20)6-16-7-17-13/h1-7,18H

Standard InChI Key:  WLTBKBGCEFFMFD-UHFFFAOYSA-N

Associated Targets(Human)

HCT-15 51914 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

XF498 12972 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SK-MEL-2 46422 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SK-OV-3 52876 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 330.14Molecular Weight (Monoisotopic): 328.9800AlogP: 2.61#Rotatable Bonds: 2
Polar Surface Area: 71.95Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.99CX Basic pKa: CX LogP: 1.64CX LogD: 1.64
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.92Np Likeness Score: -0.23

References

1. Ryu C, Yi Y, Choi IH, Chae MJ, Han J, Jung O, Lee C.  (2004)  Synthesis and Cytotoxic Activity of 6-(Substituted-Phenyl)Amino-5,8-Quinazolinediones,  13  (5): [10.1007/s00044-004-0032-8]

Source